MedTrace Logo

Establishment of a Cohort of Patients With Sepsis-associated Encephalopathy (SAE)

NCT04230447 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2023-06-15

No results posted yet for this study

Summary

In this study, the researcher involved the sepsis patients(defined by sepsis 3.0) in Peking Union Medical College Hospital. The SAE was defined as the Glasgow Coma Scale (GCS) score of less than 15 and the Non-SAE group GCS = 15. The control group was the non-infectious patients with acute disease strikes and the healthy control. After the sample collection, the RNA-sequence, metabolites and cytokines were under detection.

Conditions

  • Sepsis-Associated Encephalopathy

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Yi Li, MD

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-01
Primary Completion
2026-11-01
Completion
2030-01-14

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04230447 on ClinicalTrials.gov